CA1202897A - Agent antitumoral selectif - Google Patents

Agent antitumoral selectif

Info

Publication number
CA1202897A
CA1202897A CA000418956A CA418956A CA1202897A CA 1202897 A CA1202897 A CA 1202897A CA 000418956 A CA000418956 A CA 000418956A CA 418956 A CA418956 A CA 418956A CA 1202897 A CA1202897 A CA 1202897A
Authority
CA
Canada
Prior art keywords
antibody
cells
antitumor
cell
antitumor agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000418956A
Other languages
English (en)
Inventor
Toshihiro Nakanishi
Hajime Yoshizumi
Kozo Imai
Akira Yachi
Soldano Ferrone
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Priority to CA000418956A priority Critical patent/CA1202897A/fr
Application granted granted Critical
Publication of CA1202897A publication Critical patent/CA1202897A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA000418956A 1983-01-05 1983-01-05 Agent antitumoral selectif Expired CA1202897A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000418956A CA1202897A (fr) 1983-01-05 1983-01-05 Agent antitumoral selectif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000418956A CA1202897A (fr) 1983-01-05 1983-01-05 Agent antitumoral selectif

Publications (1)

Publication Number Publication Date
CA1202897A true CA1202897A (fr) 1986-04-08

Family

ID=4124264

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000418956A Expired CA1202897A (fr) 1983-01-05 1983-01-05 Agent antitumoral selectif

Country Status (1)

Country Link
CA (1) CA1202897A (fr)

Similar Documents

Publication Publication Date Title
EP0074279A2 (fr) Agents anti-tumeur sélectifs
AU2020200975B2 (en) New stable antibody-drug conjugate, preparation method therefor, and use thereof
JP3683270B2 (ja) 受容体Ｔｉｅを認識するモノクローナル抗体およびそれらの用途
KR0183980B1 (ko) 이중특이성 및 올리고특이성 일가 및 올리고가 수용체 및 이를 포함하는 약제학적 조성물
JP3040121B2 (ja) 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
JP3589459B2 (ja) 生物応答調節物質の新規な抗体運送システム
Russell et al. Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies
KR101921068B1 (ko) 단백질-활성제 접합체 및 이의 제조 방법
EP1024835B1 (fr) Chaine j et analogues utilises comme conjugues de ciblage de cellules epitheliales
JPH05504330A (ja) ヒトのがん腫と反応する新しい抗体
KR20000015893A (ko) 특이적으로 암세포를 검출하는 항원 결합 단편, 상기 단편을 코딩하는 뉴클레오티드 및 암의 예방 및 검출에 사용되는 이들의 용도
JPH05500944A (ja) トランスフエリンレセプタに特異的な抗体―神経薬剤の接合体
JP3340127B2 (ja) 異常増殖性疾患措置のための抗体接合体
AU722722B2 (en) Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
JPH06501705A (ja) 抗−腫瘍抗体及び生物学的活性剤の組合せによる相乗治療
CN111093701A (zh) 含有抗globo h抗体的抗体药物偶联物及其用途
CA1280690C (fr) Methode de depistage et de traitement
Pai et al. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys
WO2024041587A1 (fr) Composition pharmaceutique de conjugué anticorps-médicament
Hurwitz et al. Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice
EP0526888A2 (fr) Anticorps monocloneaux qui réagissent avec un tissu cancéreuse de pancréas humain
WO1992000089A1 (fr) Complexe immunotoxinique
CA2219961C (fr) Vasopermeabilite ameliorant les peptides de l'interleukine-2 chez l'humain et les immunoconjugues
JPH05504465A (ja) 扁平上皮癌の抗原分化のためのモノクローナル抗体および同抗体の使用法
CA2614782A1 (fr) Liaison in-vivo simultanee d'immunoconjugues a de multiples epitopes du facteur de permeabilite vasculaire sur des vaisseaux sanguins associes a des tumeurs

Legal Events

Date Code Title Description
MKEX Expiry